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ABSTRACT:  Hemoglobin E (HbE; β26Glu->Lys) is the most common variant of β-globin 
gene in Southeast Asia, and has been suggested to confer resistance against 
Plasmodium falciparum malaria. In this study 306 adult patients with P falciparum malaria 
(198 mild and 108 cerebral malaria patients) living in northwest Thailand were 
investigated to examine whether the HbE variant is associated with protection from 
cerebral malaria. Our results revealed that the sample allele frequency of HbE was not 
significantly different between mild (7.3%) and cerebral malaria (7.4%) patients. Thus, the 
HbA/HbE polymorphism would not be a major genetic factor influencing the onset of 
cerebral malaria in Thailand. 
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INTRODUCTION 
Plasmodium falciparum malaria is the most serious infectious diseases for humans. 
Approximately 400 million people are attacked by malaria annually, and ~ 3 million people 
succumb to the illness. It has been suggested that hemoglobin disorders confer 
resistance against malarial infection based on the observation that the geographical 
distribution of hemoglobin disorders globally and locally overlaps malaria endemic region. 
Hemoglobin E (HbE; β26Glu->Lys), which causes the HbE disease and the HbE trait, is 
the most common variant of β-globin gene (HBB; OMIM 141900) in malaria endemic 
regions of Southeast Asia. 
 
In Thailand, the overall allele frequency of HbE is approximately 13 %, and the frequency 
reaches 50 % in some northeastern parts of this country (Fucharoen et al., 1998). The 
high population frequency of HbE is suggested to have been attained rapidly by positive 
selection against malarial infection (Ohashi et al., 2004). In vitro studies have shown the 
inhibition of the growth of P. falciparum in HbE erythrocytes (Chotivanich et al., 2002; 
Vernes et al., 1986; Yuthavong et al., 1987). Added to these, malaria patients with the HbE 
trait were reported to have a severe complication malaria less frequently compared to 
reference patients (Hutagalung et al., 1999). Although there are many severe symptoms 
in malaria, the major cause of death due to malarial infection is cerebral malaria. It is 
therefore important, from the clinical point of view, to assess whether the HbE variant is 
associated with protection from cerebral malaria. 
 
MATERIALS AND METHODS 
Subjects 
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To examine a possible association of HbE with protection from cerebral malaria, we 
genotyped the HbA/HbE polymorphism for 306 patients with falciparum malaria living in 
northwest Thailand: 198 mild malaria and 108 cerebral malaria patients. All patients 
underwent treatment at the Hospital for Tropical Diseases, Faculty of Tropical Medicine, 
Mahidol University. For all patients, malarial infection by P. falciparum was confirmed by a 
positive blood smear for the asexual form of P. falciparum. Clinical manifestations of 
malaria were classified according to the definitions and associated criteria by the World 
Health Organization. Cerebral malaria was defined as unrousable coma, a positive result 
in tests for the presence of an asexual form of P. falciparum, and exclusion of other 
causes of coma. Mild malaria was defined as having a positive blood smear and fever 
without other causes of infection and no signs indicating severe malaria as following: high 
parasitemia (> 100,000 parasites/ml), hypoglycemia (glucose level < 22 nmol/L), severe 
anemia (hematocrit < 20% or hemoglobin level < 7.0 g/dl) or increased serum level of 
creatinine (> 3.0 mg/dl). All individuals were 13 years old or older, and the mean ages of 
patients with mild malaria and cerebral malaria patients were 25.6 and 28.6 respectively. 
This study was approved by the institutional review board of the Faculty of Tropical 
Medicine, Mahidol University, and the Research Ethics Committee of the Faculty of 
Medicine, The University of Tokyo. Informed consent was obtained from all patients. 
 
DNA Extraction, Amplification, and Sequencing 
Genomic DNAs from all the patients were purified from peripheral blood leukocytes using 
a commercially available kit (QIAmp blood kit; Qiagen, Hilden, Germany). Polymerase 
chain reaction (PCR) was performed for the HbE variant using a 5’ primer HBBex1F: 
5’-AGGAGCAGGGAGGGCAGGA-3’ and a 3’ primer HBBex1R: 
 5
5’-TCCAAGGGTAGACCACCAGC-3’. The amplification condition consisted of an initial 
denaturation at 96 C for 10 min, followed by 35 cycles of denaturation at 96 C for 30 sec, 
annealing at 60 C for 30 sec, and extension at 72 C for 30 sec were applied using a 
thermal cycler (GeneAmp PCR system 9700; Perkin-Elmer Applied Biosystems). PCR 
products were sequenced for all samples using an automated sequencer (ABI Prism 
3100; Perkin-Elmer Applied Biosystems). 
Statistical Analysis 
The difference in genotype and allele frequencies between mild and cerebral malaria 
patients was examined by Fisher’s exact probability test. 
 
RESULTS AND DISCUSSION 
Table 1 shows the genotype and allele frequencies of the HbA/HbE polymorphism in mild 
and cerebral malaria patients. The sample frequencies of HbE in mild and cerebral 
malaria patients were 7.3% and 7.4%, respectively. The sample frequency in neither 
genotype nor allele was shown to be significantly different between mild and cerebral 
malaria patients by the Fisher’s exact probability test. The present results seem to be 
inconsistent with a previous study showing that the HbE trait is associated with 
non-possession of a severe complication malaria (Hutagalung et al., 1999). However, the 
present study focused only on cerebral malaria among severe symptoms. This may be a 
part of the reason of the inconsistency. Although a case-control study requires to be 
conducted to evaluate the association between the HbE variant and the other sever 
complications of malaria, we conclude that the HbA/HbE polymorphism is not a major 
genetic factor influencing the onset of cerebral malaria. 
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 Table 1. HbE genotype and allele frequencies in Thai malaria patients 
 
 
  Mild malaria Cerebral malaria 
  (N = 198) (N = 108) 
 
Genotype frequency 
 HbE/HbE 3 (1.5 %) 0 (0.0 %) 
 HbA/HbE 23 (11.6 %) 16 (14.8 %) 
 HbA/HbA 172 (86.9 %) 92 (85.2 %) 
 
Allele frequency 
 HbE 29 (7.3 %) 16 (7.4 %)  
 HbA 367 (92.3 %) 200 (92.6 %) 
 
No significant difference was detected between mild and cerebral malaria patients by 
Fisher’s exact probability test. 
 
